| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J3285 |
Injection, treprostinil, 1 mg |
2,816 |
1,570 |
$8.92M |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
2,905 |
2,751 |
$2.78M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
1,701 |
1,663 |
$1.74M |
| J2357 |
Injection, omalizumab, 5 mg |
814 |
700 |
$1.52M |
| Z5999 |
|
51 |
50 |
$1.48M |
| 90378 |
|
536 |
439 |
$1.44M |
| S9347 |
Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
665 |
508 |
$674K |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
182 |
156 |
$384K |
| J0135 |
Injection, adalimumab, 20 mg |
368 |
336 |
$334K |
| J3590 |
Unclassified biologics |
307 |
285 |
$202K |
| A4222 |
Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) |
1,131 |
718 |
$125K |
| J1438 |
Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
122 |
118 |
$76K |
| A4221 |
Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) |
1,087 |
685 |
$67K |
| J7192 |
Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified |
25 |
12 |
$65K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
27 |
27 |
$35K |
| K0455 |
Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol) |
703 |
543 |
$16K |
| J7296 |
Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
12 |
12 |
$11K |
| J3490 |
Unclassified drugs |
458 |
419 |
$5K |
| S5000 |
Prescription drug, generic |
120 |
88 |
$3K |
| Q0512 |
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period |
400 |
294 |
$452.74 |
| Q0511 |
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period |
130 |
125 |
$377.69 |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
51 |
48 |
$326.73 |